IthaID: 237

Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: Pathogenic / Likely Pathogenic
Common Name: CD 114 CTG>CCG [Leu>Pro] HGVS Name: HBB:c.344T>C
Hb Name: Hb Durham-N.C. Protein Info: β 114(G16) Leu>Pro

Context nucleotide sequence:

Protein sequence:

Also known as: Hb Brescia

Comments: The rare Hb Durham-N.C. variant was presented in compound heterozygosity with the common IVS-I-110 (HBB: c.93-21G>A) variant, causing an early-onset severe β-Thalassaemia phenotype [PMID: 31456457]. Found in a heterozygous state in a Kurdish/Jew patient presenting with thalassaemia intermedia [PMID: 8980256]. Also reported in an Italian patient as a de novo mutation [PMID: 1301199].


Hemoglobinopathy Group: Thalassaemia and Structural Haemoglobinopathy
Hemoglobinopathy Subgroup: β-thalassaemia, β-chain variant
Allele Phenotype:Thalassaemia dominant
Stability: Unstable
Oxygen Affinity: N/A
Associated Phenotypes: Haemolytic anaemia [HP:0001878]
Ineffective erythropoiesis [HP:0010972]


Chromosome: 11
Locus: NG_000007.3
Locus Location: 71918
Size: 1 bp
Located at: β
Specific Location: Exon 3

Other details

Type of Mutation: Point-Mutation(Substitution)
Effect on Gene/Protein Function: Missense codons (Protein Structure)
Ethnic Origin: US Irish, Italian, Irish, Russian, Sicilian, Kurdish Jew
Molecular mechanism: Altered secondary structure
Inheritance: Dominant
DNA Sequence Determined: Yes

In silico pathogenicity prediction

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage. Otherwise, use this external link.


Publications / Origin

  1. Murru S, Poddie D, Sciarratta GV, Agosti S, Baffico M, Melevendi C, Pirastu M, Cao A, A novel beta-globin structural mutant, Hb Brescia (beta 114 Leu-Pro), causing a severe beta-thalassemia intermedia phenotype., Hum. Mutat., 1(2), 124-8, 1992 PubMed
  2. Cürük MA, Molchanova TP, Postnikov YuV , Pobedimskaya DD, Liang R, Baysal E, Kolodey S, Smetanina NS, Tokarev YuN , Rumyantsev AG, Beta-thalassemia alleles and unstable hemoglobin types among Russian pediatric patients., American journal of hematology, 46(4), 329-32, 1994 PubMed
  3. de Castro CM, Devlin B, Fleenor DE, Lee ME, Kaufman RE, A novel beta-globin mutation, beta Durham-NC [beta 114 Leu-->Pro], produces a dominant thalassemia-like phenotype., Blood, 83(4), 1109-16, 1994 PubMed
  4. Rund D, Oron-Karni V, Filon D, Goldfarb A, Rachmilewitz E, Oppenheim A, Genetic analysis of beta-thalassemia intermedia in Israel: diversity of mechanisms and unpredictability of phenotype., Am. J. Hematol., 54(1), 16-22, 1997 PubMed
  5. Cannata M, Cassarà F, Vinciguerra M, Licari P, Passarello C, Leto F, Lo Pinto C, Pitrolo L, Ganci R, Maggio A, Giambona A, Double Heterozygosity for Hb Durham-N.C. (: c.344T>C) [β114(G16)Leu→Pro] and the IVS-I-110 (: c.93-21G>A) Causing a Severe β-Thalassemia Phenotype., Hemoglobin, 43(3), 210-213, 2019 PubMed
Created on 2010-06-16 16:13:15, Last reviewed on 2020-06-26 15:08:09 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.